Ask your doctor…and look for a miracle inhaler for some COPDers. The PATHOS study published in the Journal of Internal Medicine shows that SYMBICORTR TurbuhalerR (budesonide/formoterol) must be some kind of miracle inhaler for chronic obstructive pulmonary disease (COPD) patients.
Among other advantages, the PATHOS study
showed a 26% decrease in exacerbations for moderate –
inhaler has to be bliss for those COPDers able to use it.
I’ve used Foradil Aerolizer
(Formoterol Fumarate Inhalation Powder) for
years. The Fulmarate
ingredient seems to make it a relative of
and it is the single inhaler I take (of
three) that noticeably helps me breathe easier.
Best of all is the promise shown in the PATHOS study:
“Dr. Kjell Larsson, Professor of Respiratory Medicine at the Karolinska
Institute in Stockholm said: “So called ‘real world’ studies, such as
PATHOS, together with randomised prospective studies, play an important role
in answering questions about the value of medicines in delivering better,
cost-effective healthcare to patients. These findings can help physicians
and the healthcare community to understand disease patterns and create a
fuller picture of treatment effects and what patients are experiencing.”
The only side-affect/warning I can find might be for asthma patients.
-16558063/ …thanks to Linda W EFFORTS <www.emphysema.net>
Thanks for listening … Sharon O’Hara < firstname.lastname@example.org